Abstract
Cancer diagnostics and treatment monitoring rely on sensing and counting of rare cells such as cancer circulating tumor cells (CTCs) in blood. Many analytical techniques have been developed to reliably detect and quantify CTCs using unique physical shape and size of tumor cells and/or distinctive patterns of cell surface biomarkers. Main problems of CTC bioanalysis are in the small number of cells that are present in the circulation and heterogeneity of CTCs. In this chapter, we describe recent progress towards the selection and application of synthetic DNA or RNA aptamers to capture and detect CTCs in blood. Antibody-based approaches for cell isolation and purification are limited because of an antibody’s negative effect on cell viability and purity. Aptamers transform cell isolation technology, because they bind and release cells on-demand. The unique feature of anti-CTC aptamers is that the aptamers are selected for cell surface biomarkers in their native state, and conformation without previous knowledge of their biomarkers. Once aptamers are produced, they can be used to identify CTC biomarkers using mass spectrometry. The biomarkers and corresponding aptamers can be exploited to improve cancer diagnostics and therapies .
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897–6904
Alunni-Fabbroni M, Sandri M (2010) Circulating tumour cells in clinical practice: methods of detection and possible characterization. Methods 50(4):289–297
Chen G, Huang C, Wu H et al (2014) Isolating and concentrating rare cancerous cells in large sample volumes of blood by using dielectrophoresis and stepping electric fields. Biochip J 8(2):67–74
Dickey D, Giangrande P (2016) Oligonucleotide aptamers: a next-generation technology for the capture and detection of circulating tumor cells. Methods 97:94–103
Hatanaka H, Yasukawa T, Mizutani F (2011) Detection of surface antigens on living cells through incorporation of immunorecognition into the distinct positioning of cells with positive and negative dielectrophoresis. Anal Chem 83(18):7207–7212
Jacob K, Sollier C, Jobodo N (2007) Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics 4(6):741–756
Jayasena S (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45(9):1628–1650
Joosse S, Pantel K (2013) Biologic challenges in the detection of circulating tumor cells. Cancer Res 73(1):8–11
Lampignano R, Schneck H, Neumann M et al (2016) Detection of EpCAM-negative circulating tumor cells in metastatic breast cancer patients by using VyCAP filters technology. Oncol Res Treat 39:48–48
Li S, Chen N, Zhang Z et al (2013) Endonuclease-responsive aptamer-functionalized hydrogel coating for sequential catch and release of cancer cells. Biomaterials 34(2):460–469
Liu G, Mao X, Phillips J et al (2009) Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem 81(24):10013–10018
Maremanda N, Roy K, Kanwar R et al (2015) Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells. Biomicrofluidics 9(5):054110
Martin J, Phillips J, Parekh P et al (2011) Capturing cancer cells using aptamer-immobilized square capillary channels. Mol BioSyst 7(5):1720–1727
Nellore B, Kanchanapally R, Pramanik A et al (2015) Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells. Bioconjug Chem 26(2):235–242
Punnoose E, Atwal S, Liu W et al (2012) Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18(8):2391–2401
Qu L, Xu J, Tan X et al (2014) Dual-aptamer modification generates a unique Interface for highly sensitive and specific electrochemical detection of tumor cells. ACS Appl Mater Interfaces 6(10):7309–7315
Rusconi C, Scardino E, Layzer J et al (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419(6902):90–94
Sefah K, Meng L, Lopez-Colon D et al (2010) DNA aptamers as molecular probes for colorectal cancer study. PLoS One 5(12):e14269
Shangguan D, Li Y, Tang Z et al (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 103(32):11838–11843
Shen Q, Xu L, Zhao L et al (2013) Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Adv Mater 25(16):2368–2373
Sheng W, Chen T, Katnath R et al (2012) Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal Chem 84(9):4199–4206
Sheng W, Chen T, Tan W et al (2013) Multivalent DNA Nanospheres for enhanced capture of cancer cells in microfluidic devices. ACS Nano 7(8):7067–7076
Sheng W, Ogunwobi O, Chen T et al (2014) Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip 14(1):89–98
Sun N, Wang J, Ji L et al (2015) A cellular compatible chitosan nanoparticle surface for isolation and in situ culture of rare number CTCs. Small 11(40):5444–5451
Tang Z, Shangguan D, Wang K et al (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 79(13):4900–4907
Wan Y, Tan J, Asghar W et al (2011) Velocity effect on aptamer-based circulating tumor cell isolation in microfluidic devices. J Phys Chem B 115(47):13891–13896
Wan Y, Liu Y, Allen P et al (2012) Capture, isolation and release of cancer cells with aptamer-functionalized glass bead array. Lab Chip 12(22):4693–4701
Wang L, Zheng Q, Zhang Q et al (2012) Detection of single tumor cell resistance with aptamer biochip. Oncol Lett 4(5):935–940
Wehbe M, Labib M, Muharemagic D et al (2015) Switchable aptamers for biosensing and bioseparation of viruses (SwAps-V). Biosens Bioelectron 67:280–286
Zamay G, Kolovskaya O, Zamay T et al (2015) Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol Ther 23(9):1486–1496
Zeng Z, Tung C, Zu Y (2014) A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells. Mol Ther Nucl Acid 3:e184
Zhang J, Li S, Liu F et al (2015) SELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients. PLoS One 10(3):e0121920
Zhao L, Tang C, Xu L et al (2016) Enhanced and differential capture of circulating tumor cells from lung cancer patients by microfluidic assays using aptamer cocktail. Small 12(8):1072–1081
Zheng F, Cheng Y, Wang J et al (2014) Aptamer-functionalized barcode particles for the capture and detection of multiple types of circulating tumor cells. Adv Mater 26(43):7333–7338
Acknowledgements
This work was supported by Ministry of Education and Science of Russian Federation Federal Target Program # 14.604.21.0105.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Zamay, A.S., Zamay, G.S., Kolovskaya, O.S., Zamay, T.N., Berezovski, M.V. (2017). Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics. In: Magbanua, M., Park, J. (eds) Isolation and Molecular Characterization of Circulating Tumor Cells. Advances in Experimental Medicine and Biology, vol 994. Springer, Cham. https://doi.org/10.1007/978-3-319-55947-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-55947-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55946-9
Online ISBN: 978-3-319-55947-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)